Standardization and quality assessment for clinical grade mesenchymal stem cells from human adipose tissue.
APA
Debnath T, Chelluri LK (2019). Standardization and quality assessment for clinical grade mesenchymal stem cells from human adipose tissue.. Hematology, transfusion and cell therapy, 41(1), 7-16. https://doi.org/10.1016/j.htct.2018.05.001
MLA
Debnath T, et al.. "Standardization and quality assessment for clinical grade mesenchymal stem cells from human adipose tissue.." Hematology, transfusion and cell therapy, vol. 41, no. 1, 2019, pp. 7-16.
PMID
30793099
Abstract
[BACKGROUND] Mesenchymal stem cells have immense potential in stem cell-based therapies, however there is a pre-requisite to develop a curative cell dose. Adipose tissue-derived mesenchymal stem cells are promising mainly due to their potential abundance, immunomodulatory effect and remarkable differentiation potential. Nevertheless, senescence may develop during their expansion due to the incidence of genetic instability. Hence, it is important to attain an ideal balance between mesenchymal stem cell growth, quality and genetic integrity before their clinical use.
[METHODS] Stromal vascular fraction was obtained from omentum tissue of patients undergoing liposuction procedures for morbid obesity. This study standardized a closed system protocol which can be utilized for clinical grade stem cell derivation. Stages of cell growth and characterization of human adipose tissue-derived mesenchymal stem cells were also assessed along with the chromosomal stability in these cultures.
[RESULTS] Human adipose tissue-derived mesenchymal stem cells maintained their spindle-shaped morphology and were able to proliferate and renew, confirming their suitability for cultivation and generate clinical grade mesenchymal stem cells. Immunophenotyping indicates that the cells expressed cluster of differentiation (CD)73/CD90/CD105, mesenchymal stem-cell markers, while lacked CD34/CD45/ Human Leukocyte antigen-antigen D related (HLA-DR) expression (hematopoietic cell markers). A cell cycle study demonstrated growth kinetics under culture conditions. Human adipose tissue derived mesenchymal stem cells expressed normal cell karyotype by chromosomal G-banding indicating their genetic stability at Passage 5. Mesenchymal stem cells also demonstrated trilineage differentiation.
[CONCLUSIONS] Availability of adipose tissue in abundance is a major advantage for clinical applications. Furthermore, detailed characterization of human adipose tissue-derived mesenchymal stem cells, their genomic stability and differentiation potential from stromal vascular fraction of human adipose tissue would help assist in tissue regeneration and repair.
[METHODS] Stromal vascular fraction was obtained from omentum tissue of patients undergoing liposuction procedures for morbid obesity. This study standardized a closed system protocol which can be utilized for clinical grade stem cell derivation. Stages of cell growth and characterization of human adipose tissue-derived mesenchymal stem cells were also assessed along with the chromosomal stability in these cultures.
[RESULTS] Human adipose tissue-derived mesenchymal stem cells maintained their spindle-shaped morphology and were able to proliferate and renew, confirming their suitability for cultivation and generate clinical grade mesenchymal stem cells. Immunophenotyping indicates that the cells expressed cluster of differentiation (CD)73/CD90/CD105, mesenchymal stem-cell markers, while lacked CD34/CD45/ Human Leukocyte antigen-antigen D related (HLA-DR) expression (hematopoietic cell markers). A cell cycle study demonstrated growth kinetics under culture conditions. Human adipose tissue derived mesenchymal stem cells expressed normal cell karyotype by chromosomal G-banding indicating their genetic stability at Passage 5. Mesenchymal stem cells also demonstrated trilineage differentiation.
[CONCLUSIONS] Availability of adipose tissue in abundance is a major advantage for clinical applications. Furthermore, detailed characterization of human adipose tissue-derived mesenchymal stem cells, their genomic stability and differentiation potential from stromal vascular fraction of human adipose tissue would help assist in tissue regeneration and repair.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | liposuction
|
지방흡입 | dict | 1 | |
| 해부 | mesenchymal stem cells
|
scispacy | 1 | ||
| 해부 | stem
|
scispacy | 1 | ||
| 해부 | cell
|
scispacy | 1 | ||
| 해부 | Adipose tissue-derived mesenchymal stem cells
|
scispacy | 1 | ||
| 해부 | mesenchymal stem cell
|
scispacy | 1 | ||
| 해부 | omentum tissue
|
scispacy | 1 | ||
| 해부 | stem cell
|
scispacy | 1 | ||
| 해부 | chromosomal
|
scispacy | 1 | ||
| 해부 | spindle-shaped
|
scispacy | 1 | ||
| 해부 | cells
|
scispacy | 1 | ||
| 해부 | mesenchymal stem-cell
|
scispacy | 1 | ||
| 해부 | hematopoietic cell
|
scispacy | 1 | ||
| 해부 | adipose tissue
|
scispacy | 1 | ||
| 해부 | tissue
|
scispacy | 1 | ||
| 약물 | [BACKGROUND] Mesenchymal stem cells
|
scispacy | 1 | ||
| 약물 | [RESULTS] Human adipose tissue-derived mesenchymal stem cells
|
scispacy | 1 | ||
| 질환 | obesity
|
C0028754
Obesity
|
scispacy | 1 | |
| 기타 | human adipose tissue
|
scispacy | 1 | ||
| 기타 | human adipose tissue-derived mesenchymal stem cells
|
scispacy | 1 | ||
| 기타 | Human Leukocyte antigen-antigen D related (
|
scispacy | 1 | ||
| 기타 | Human adipose tissue derived mesenchymal stem cells
|
scispacy | 1 | ||
| 기타 | stromal vascular
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Quantitative Assessment of Cannula Kinematics in Liposuction Surgical Procedures Using a Marker-Based Tracking System.
- Fat harvesting protocol for enhanced stem cell viability - pilot study.
- Scarless Infragluteal Fixation (SIF): Correction of Post-Liposuction Infragluteal Deformity.
- [Super microsurgical lymphaticovenular anastomosis for limb lymphedema: An outcome analysis based on clinical stage and indocyanine green pattern].
- Iatrogenic pneumothorax associated with surgeries at anatomically thoracic-adjacent and non-adjacent sites: case report and scoping review.